11 news items
TD Cowen Maintains Buy on AerCap Holdings, Raises Price Target to $105
AER
9 May 24
TD Cowen analyst Helane Becker maintains AerCap Holdings (NYSE:AER) with a Buy and raises the price target from $100 to $105.
Deutsche Bank Maintains Buy on AerCap Holdings, Raises Price Target to $110
AER
9 May 24
Deutsche Bank analyst Koosh Patel maintains AerCap Holdings (NYSE:AER) with a Buy and raises the price target from $95 to $110.
TD Cowen Maintains Buy on AerCap Holdings, Raises Price Target to $100
AER
2 May 24
TD Cowen analyst Helane Becker maintains AerCap Holdings (NYSE:AER) with a Buy and raises the price target from $95 to $100.
Barclays Maintains Overweight on AerCap Holdings, Raises Price Target to $94
AER
2 May 24
Barclays analyst Terry Ma maintains AerCap Holdings (NYSE:AER) with a Overweight and raises the price target from $93 to $94.
Susquehanna Maintains Positive on AerCap Holdings, Raises Price Target to $100
AER
2 May 24
Susquehanna analyst Christopher Stathoulopoulos maintains AerCap Holdings (NYSE:AER) with a Positive and raises the price target from $90 to $100.
s4t bcg5puz5ypn5knrddzd5lw5siakfdyydz5tsoq
AER
26 Feb 24
.
These analysts made changes to their price targets on AerCap after the company reported quarterly results.
Barclays raised
oizwi6hcegmbdopcsct5of9i qhkemj
AER
26 Feb 24
Susquehanna analyst Christopher Stathoulopoulos maintains AerCap Holdings (NYSE:AER) with a Positive and raises the price target from $80 to $90.
yv97b47b1vthvqg617tf8nubgzzyazvepp r1b2jqqycv6
AER
GPS
HCP
26 Feb 24
target for The Gap, Inc. (NYSE:GPS) from $16 to $20. JP Morgan
8z7vt2 4m
AER
26 Feb 24
Barclays analyst Mark Devries maintains AerCap Holdings (NYSE:AER) with a Overweight and raises the price target from $84 to $93.
o4kqfhwfuqwnb0g2trv9bxavrl9000 kk2kvz13l2emgrqxpk1ugj
AER
AXTI
MNPR
23 Feb 24
, gaining 37% to $1.5306 after the company announced preclinical data for its MNPR-101 radiopharma program targeting advanced cancers
228494uzueed swj0rt3wbb4nbcy2eczh8
AER
AXTI
CRGEQ
23 Feb 24
were also up, gaining 52% to $1.70 after the company announced preclinical data for its MNPR-101 radiopharma program targeting advanced cancers
- Prev
- 1
- Next